Bergeson & Campbell, P.C. is an AV-rated (highest ranking) Washington, D.C. law firm focusing on conventional and nanoscale, industrial, agricultural, and specialty chemical product regulation and approval matters, including TSCA matters, FIFRA/FQPA matters, FDA medical device and product approval, registration and data compensation arbitrations, chemical product litigation, and associated business counseling and litigation issues. Bergeson & Campbell`s clients are involved in many businesses, including conventional and nanoscale, basic, specialty, and agricultural and antimicrobial chemicals; biotechnology, nanotechnology, and emerging transformative technologies; pharmaceuticals, medical devices, and diagnostic products; fibers; paints and coatings; printing and publishing; and plastic products. We represent and counsel individuals, business entities, trade associations, and industry coalitions. Our professionals conduct advocacy before EPA, FDA, HHS, OSHA, ATSDR, NTP, OMB, the Departments of State, Interior, and U.S. Special Trade Representative, state governmental bodies, federal and state courts, and in other forums, and play active roles in business strategy development, compliance planning, toxic tort defense, acquisitions, and related activities.